Clinical trials
Emphysema or COPD clinical trials
Below are recruiting emphysema or copd clinical trials, each written for real people, not researchers. We’re tracking 432 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06776731Recruiting
Does extra oxygen during rehab help lung disease patients?
This study tests whether breathing extra oxygen during outpatient pulmonary rehabilitation helps people with COPD. Participants will have their oxygen levels checked during exercise to see if extra oxygen improves their rehab results.
Winterthur, Canton of ZurichAges 18 years+ - NCT06782724RecruitingPhase 2
Psilocybin therapy for distress in advanced illness
This trial tests whether a single dose of psilocybin (a psychedelic medicine) can help reduce depression and distress in people with advanced lung disease, ALS, multiple sclerosis, or Parkinson's. You would receive preparation, the drug, and follow-up support in a safe, supervised setting.
PragueAges 18 years+ - NCT06798077Recruiting
Chronic Lung Disease and Multiple Health Issues Study
This study follows people with chronic airway diseases like COPD, asthma, or bronchiectasis who were recently hospitalized for a worsening of their condition. It aims to understand how these diseases affect overall health and other medical problems over time.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06800586Recruiting
Air pollution and health: new early warning signs
This study looks for new early warning signs (biomarkers) of how air pollution affects lung and blood health. It is for people with COPD, lung cancer, or leukemia who have never smoked much, as well as for healthy hospital workers.
Bologna, BolognaAges 18 years+ - NCT06850961Recruiting
Digital health app for COPD self-management
This study tests a digital health app to help you manage COPD symptoms on your own. It focuses on people who have trouble with mucus and want to use a smartphone for their care.
Bergen, NorwayAges 18–90 - NCT06882265Recruiting
Remote monitoring for people on long-term oxygen therapy
This study tests if monitoring your vital signs remotely (like oxygen levels and heart rate) can help improve care for people who need long-term oxygen therapy due to COPD or ILD. It may help you feel more supported at home.
São Paulo, São PauloAges 18–85 - NCT06892210RecruitingPhase 4
Steroid comparison for COPD flare-ups
This trial compares two common steroids, hydrocortisone and prednisolone, to see which works better for treating COPD flare-ups. It may help you recover faster from a sudden worsening of your breathing.
Rønne, BornholmAges 40 years+ - NCT06909773Recruiting
COPD testing in people with heart disease
This study looks for undiagnosed COPD in people with heart conditions like coronary heart disease, atrial fibrillation, or chronic heart failure. If you have heart disease and are over 40, you may join to see if you also have COPD and benefit from combined care.
AnqingAges 40 years+ - NCT06956742Recruiting
Breathing device study for COPD shortness of breath after exercise
This trial tests a device that briefly opens your airways to help release trapped air after exercise. It may reduce shortness of breath and improve your daily life with COPD.
Rouen, NormandyAges 18 years+ - NCT06959095RecruitingPhase 3
Depemokimab for COPD with type 2 inflammation
This trial tests a new medicine, depemokimab, given as an injection to help reduce flare-ups (exacerbations) in adults with moderate to severe COPD who have a certain type of inflammation. The goal is to see if it can keep you healthier for longer with fewer serious breathing attacks.
Loxahatchee Groves, FloridaAges 40–80 - NCT06961214RecruitingPhase 3
Testing a new biologic for COPD with type 2 inflammation
This trial tests a medicine called depemokimab for people with COPD and a specific type of inflammation (type 2). It aims to see if it can reduce flare-ups when added to standard inhaler therapy.
Sheffield, AlabamaAges 40–80 - NCT06983366Recruiting
Lung sliding index for diagnosing lung conditions
This study uses an ultrasound-based measurement called the Lung Sliding Index to help tell different lung diseases apart. Researchers want to see if it can be a useful and simple tool for doctors.
AsyutAges 18 years+ - NCT07003399Recruiting
Breathing Muscle Function in Sleep Apnea and COPD
This study looks at how the diaphragm (the main breathing muscle) and the drive to breathe work in people with sleep apnea, COPD, or both. Researchers want to compare these groups with healthy volunteers to better understand breathing problems.
Nanjing, JiangsuAges 18–80 - NCT07015216Recruiting
Virtual reality training for COPD patients
This study tests if virtual reality combined with physical and mental tasks can improve muscle oxygen levels in people with COPD. It aims to find a more engaging way to help you exercise and feel better.
IstanbulAges 18–70 - NCT07022704Recruiting
Doxapram to help COPD patients breathe easier off the ventilator
This trial tests if the drug doxapram can improve diaphragm movement in COPD patients who are being taken off a ventilator during a breathing trial. It aims to make the transition smoother and more successful.
Cairo, Cairo GovernorateAges 20–65 - NCT07025382Recruiting
Home vs. center rehab for COPD patients
This trial compares doing pulmonary rehab at home via video calls versus going to a center. It aims to see which way helps people with COPD breathe better and feel healthier.
MontivilliersAges 45–80 - NCT07030881Recruiting
Spacer use in older adults with COPD or asthma on triple therapy
This trial tests whether using a spacer with your inhaler can lower the risk of serious flare-ups for people over 65 who have COPD or asthma and are already on triple therapy.
Hefei, AnhuiAges 65 years+ - NCT07031336Recruiting
Photon-counting CT for better lung scans
This trial is testing a new type of CT scanner (photon-counting CT) for chest imaging. If you are already in the Duke-COPDGene study, you may be invited to also get this special scan to see if it gives clearer pictures of your lungs.
Durham, North CarolinaAges Any age - NCT07039669RecruitingPhase 3
Study of 611 for moderate to severe COPD in adults
This trial tests a new medicine called 611 for people with moderate to severe COPD. It aims to see if adding 611 to your current treatments can help prevent flare-ups and improve symptoms.
Beijing, Beijing MunicipalityAges 40–85 - NCT07047092RecruitingPhase 3
CPAP vs. NIV for sleep apnea in COPD after breathing failure
This trial compares two breathing devices (CPAP and NIV) for people with both COPD and sleep apnea who recently needed breathing help in the hospital. The goal is to see which device works better at preventing future breathing emergencies.
ParisAges 18–84 - NCT07050823Recruiting
Studying chronic breathing issues and other health problems
This trial looks at how long-term health conditions like heart disease, diabetes, or high blood pressure might affect breathing problems. The goal is to better understand and help people with both issues.
São Carlos, São PauloAges 30 years+ - NCT07060079Recruiting
Using entropy to measure sleep breathing in chronic lung disease
This study uses a special mathematical method called entropy to better understand sleep-disordered breathing in people with chronic respiratory disease. If you have a long-term lung condition, this research could help improve how sleep breathing problems are detected and managed.
LondonAges 18 years+ - NCT07068438Recruiting
Pulsed electric field for chronic bronchitis
This study tests a new treatment that uses brief electric pulses to clear blocked airways in people with chronic bronchitis. It might help if you have a long-term cough with mucus and standard medicines aren't enough.
Hefei, AnuiAges 35–80 - NCT07073950RecruitingPhase 4
A study on a triple inhaler for COPD with hyperinflation
This study tests a triple-combination inhaler (budesonide, glycopyrronium, formoterol) against a placebo inhaler to see how it affects your heart and lungs if you have COPD and over-inflated lungs.
AhrensburgAges 40–80
Hear when a new Emphysema or COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for emphysema or copd?
- Yes. Clin2 currently lists 432 recruiting emphysema or copd studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a emphysema or copd trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a emphysema or copd trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.